Hedge Fund Industry News

A collection of Hedge Fund latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Melos Ambaye - Bitcoin Trapped in Fragile Trading as Hedge Funds Pivot to Cash
Bitcoin Trapped in Fragile Trading as Hedge Funds Pivot to Cash
Bloomberg

Bitcoin settled into a narrow trading range with investors still seeking direction almost two weeks after a market collapse that wiped out the last remnants of gains registered since since Donald Trump won re-election. The downturn appears to have…

bloomberg.com - Liza Tetley - Nadeem's Macro Hedge Fund Deem Closing to New Cash at $3 Billion
Nadeem's Macro Hedge Fund Deem Closing to New Cash at $3 Billion
Bloomberg

Asfandyar Nadeem is closing his macro hedge fund firm to new cash, joining a raft of peers who have been shutting the doors on clients to help manage their size. His London-based Deem Global will stop taking money from new clients on March 1 as…

yahoo.com - Noor Ul Ain Rehman - Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds?
Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds?
Yahoo!

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is one of the best immunotherapy stocks to buy according to hedge funds. On February 5, Goldman Sachs lifted the price target on Iovance Biotherapeutics Inc. (NASDAQ:IOVA) to $2 from $1.50 while…

yahoo.com - Noor Ul Ain Rehman - Why AstraZeneca PLC (AZN) is One of the Best Immunotherapy Stocks to Buy According to Hedge Funds
Why AstraZeneca PLC (AZN) is One of the Best Immunotherapy Stocks to Buy According to Hedge Funds
Yahoo!

AstraZeneca PLC (NASDAQ: AZN) is one of the best immunotherapy stocks to buy according to hedge funds. AstraZeneca PLC (NASDAQ:AZN) received an update from Deutsche Bank on February 16, with the firm reiterating a Sell rating on the stock and…

barchart.com - Subhasree Kar - Billionaire Hedge Fund Tiger Global Is Betting Big on This 1 Stock
Billionaire Hedge Fund Tiger Global Is Betting Big on This 1 Stock
Barchart.com

Tiger Global Management, the New York-based billionaire investor Chase Coleman-led hedge fund and venture powerhouse, is making headlines again with an aggressive pivot into the newly public Wealthfront Corporation (WLTH), signaling strong…

barchart.com - Faisal Humayun Khan - Famous Hedge Fund Duquesne Is Buying Up This 1 Big Bank Stock. Should You?
Famous Hedge Fund Duquesne Is Buying Up This 1 Big Bank Stock. Should You?
Barchart.com

Goldman Sachs (GS) stock has been in a steady uptrend with returns of 38% in the last 52 weeks. This rally has been supported by healthy quarterly results, with Goldman dominating the dealmaking market in 2025. As a matter of fact, the investment…

bloomberg.com - Veena Ali-Khan - Toymaker Funko Attracts Deal-Minded Investor Pleasant Lake
Toymaker Funko Attracts Deal-Minded Investor Pleasant Lake
Bloomberg

Hedge fund Pleasant Lake Partners disclosed it's an investor in toymaker Funko Inc., and is pushing the company to launch a formal sale process that it said it could participate in. Pleasant Lake said in a filing Thursday that it accumulated a…

nytimes.com - Maureen Farrell - Blue Owl Capital Sets Off New Fears About the Private Credit Industry
Blue Owl Capital Sets Off New Fears About the Private Credit Industry
The New York Times

|Blue Owl Sets Off New Private Credit Fears https://www.nytimes.com/2026/02/19/business/blue-owl-stock-private-credit.html Shares of Blue Owl Capital, the giant private lender, plunged on Thursday after the company announced that it was changing…

marketwatch.com - Financials Down After Blue Owl Halts Redemptions at Fund -- Financials Roundup
Financials Down After Blue Owl Halts Redemptions at Fund -- Financials Roundup
MarketWatch

The slowdown of redemptions, which is often used to prevent a disorderly exodus from funds, sent a chill through Wall Street. Blue Owl's maneuver 'could start a chain of problems in private credit,' said Lorenzo Di Mattia, manager of hedge fund…

yahoo.com - Soumya Eswaran - Strong Earnings Growth Lifted Novanta (NOVT) in Q4
Strong Earnings Growth Lifted Novanta (NOVT) in Q4
Yahoo!

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across all major indices, yet underlying conditions…

yahoo.com - Soumya Eswaran - Digi International (DGII) Benefited from Faster Than Expected Recurring Services Revenue
Digi International (DGII) Benefited from Faster Than Expected Recurring Services Revenue
Yahoo!

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across all major indices, yet underlying conditions…

marketwatch.com - Communications Services Up on Growth Optimism -- Communications Services Roundup
Communications Services Up on Growth Optimism -- Communications Services Roundup
MarketWatch

Communications-services rose amid optimism about the sector's growth outlook. Shares of Australian carrier Telstra closed at the highest level since 2017, after it increased the size of its buyback and exceeded analysts' interim dividend forecasts.

bloomberg.com - Daniel Cancel  - BNP Plans to Expand Miami Office Following 47% Revenue Growth
BNP Plans to Expand Miami Office Following 47% Revenue Growth
Bloomberg

BNP Paribas SA, which opened a Miami office in late 2023, is expanding headcount and holding internal discussions to add more business lines as its bet on serving the hedge fund community and other institutional investors locally pays off. After…

yahoo.com - Noor Ul Ain Rehman - Where is Pfizer Inc. (PFE) Headed?
Where is Pfizer Inc. (PFE) Headed?
Yahoo!

Pfizer Inc. (NYSE: PFE) is one of the best immunotherapy stocks to buy according to hedge funds. On February 12, Daiwa downgraded Pfizer Inc. (NYSE:PFE) to Neutral from Outperform and set a $27 price target. In another development, Pfizer Inc.

yahoo.com - Noor Ul Ain Rehman - Where is Novartis AG (NVS) Headed?
Where is Novartis AG (NVS) Headed?
Yahoo!

Novartis AG (NYSE: NVS) is one of the best immunotherapy stocks to buy according to hedge funds. Novartis AG (NYSE:NVS) announced on February 13 final results from the Phase III ALIGN study, stating that Vanrafia (atrasentan) showed a positive…

Receive a Daily briefing on Hedge Fund Industry News

Get Started